β-Amyloid (1-42), rat TFA
Need Assistance?
  • US & Canada:
    +
  • UK: +

β-Amyloid (1-42), rat TFA

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

The TFA form of β-Amyloid (1-42), rat, a 42-aa peptide, shows cytotoxic effect on acute hippocampal slices, and used in the research of Alzheimer's disease.

Category
Peptide Inhibitors
Catalog number
BAT-009398
Molecular Formula
C201H308F3N53O61S
Molecular Weight
4532.04
Synonyms
Lys-Val-Lys-Gly-Leu-Ile-Asp-Gly-Ala-His-Ile-Gly-Asp-Leu-Val-Tyr-Glu-Phe-Met-Asp-Ser-Asn-Ser-Ala-Ile-Phe-Arg-Glu-Gly-Val-Gly-Ala-Gly-His-Val-His-Val-Ala-Gln-Val-Glu-Phe; beta-Amyloid (1-42), rat TFA
Sequence
DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVVIA
Storage
Store at -20°C 3 years powder; -80°C 2 years in solvent
Solubility
Soluble in water, DMSO
1. Controlled in situ preparation of A beta(1-42) oligomers from the isopeptide "iso-A beta(1-42)", physicochemical and biological characterization
Zsolt Bozso, et al. Peptides. 2010 Feb;31(2):248-56. doi: 10.1016/j.peptides.2009.12.001. Epub 2009 Dec 6.
Beta-amyloid (A beta) peptides play a crucial role in the pathology of the neurodegeneration in Alzheimer's disease (AD). Biological experiments (both in vitro and animal model studies of AD) require synthetic A beta peptides of standard quality, aggregation grade, neurotoxicity and water solubility. The synthesis of A beta peptides has been difficult, owing to their hydrophobic character, poor solubility and high tendency for aggregation. Recently an isopeptide precursor (iso-A beta(1-42)) was synthesized by Fmoc-chemistry and transformed at neutral pH to A beta(1-42) by O-->N acyl migration in a short period of time. We prepared the same precursor peptide using Boc-chemistry and studied the transformation to A beta(1-42) by acyl migration. The peptide conformation and aggregation processes were studied by several methods (circular dichroism, atomic force and transmission electron microscopy, dynamic light scattering). The biological activity of the synthetic A beta(1-42) was measured by ex vivo (long-term potentiation studies in rat hippocampal slices) and in vivo experiments (spatial learning of rats). It was proven that O-->N acyl migration of the precursor isopeptide results in a water soluble oligomeric mixture of neurotoxic A beta(1-42). These oligomers are formed in situ just before the biological experiments and their aggregation grade could be standardized.
2. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants
A Lomakin, D S Chung, G B Benedek, D A Kirschner, D B Teplow Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1125-9. doi: 10.1073/pnas.93.3.1125.
We have studied the fibrillogenesis of synthetic amyloid beta-protein-(1-40) fragment (A beta) in 0.1 M HCl. At low pH, A beta formed fibrils at a rate amenable to detailed monitoring by quasi-elastic light-scattering spectroscopy. Examination of the fibrils with circular dichroism spectroscopy and electron microscopy showed them to be highly similar to those found in amyloid plaques. We determined the hydrodynamic radii of A beta aggregates during the entire process of fibril nucleation and growth. Above an A beta concentration of approximately 0.1 mM, the initial rate of elongation and the final size of fibrils were independent of A beta concentration. Below an A beta concentration of 0.1 mM, the initial elongation rate was proportional to the peptide concentration, and the resulting fibrils were significantly longer than those formed at higher concentration. We also found that the surfactant n-dodecylhexaoxyethylene glycol monoether (C12E6) slowed nucleation and elongation of fibrils in a concentration-dependent manner. Our observations are consistent with a model of A beta fibrillogenesis that includes the following key steps: (i) peptide micelles form above a certain critical A beta concentration, (ii) fibrils nucleate within these micelles or on heterogeneous nuclei (seeds), and (iii) fibrils grow by irreversible binding of monomers to fibril ends. Interpretation of our data enabled us to determine the sizes of fibril nuclei and A beta micelles and the rates of fibril nucleation (from micelles) and fibril elongation. Our approach provides a powerful means for the quantitative assay of A beta fibrillogenesis.
3. Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide
C L Shen, M C Fitzgerald, R M Murphy Biophys J. 1994 Sep;67(3):1238-46. doi: 10.1016/S0006-3495(94)80593-4.
beta-amyloid peptide (A beta) is the major protein component of senile plaques and cerebrovascular amyloid deposits in Alzheimer's patients. Several researchers have demonstrated that A beta is neurotoxic in in vitro and in vivo systems. Peptide aggregation state and/or conformation might play a significant role in determining the toxicity of the peptide. The size and flexibility of fibrils formed from the synthetic peptide beta (1-39), corresponding to the first 39 residues of A beta, were determined. Samples were prepared either directly from lyophilized peptide or diluted from a 10 mg/ml stock solution in 0.1% trifluoroacetic acid (TFA). All samples had a final peptide concentration of 0.5 mg/ml, a final pH of 7.4, and a final NaCl concentration of 0.14 M. The molecular weight and linear density of the fibrils increased with increasing pre-incubation time in TFA, based on static light scattering measurements. Analysis of the angular dependence of the intensity of scattered light indicated that the fibrils were semi-flexible chains and that the fibril flexibility decreased with increasing pre-incubation time in TFA. There was a concomitant change in phase behavior from precipitation to gelation with the decrease in fibril flexibility.
Online Inquiry
Verification code
Inquiry Basket